These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2362794)

  • 81. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord.
    Fu KK; Woodhouse RJ; Quivey JM; Phillips TL; Dedo HH
    Cancer; 1982 Feb; 49(4):655-8. PubMed ID: 7055780
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions.
    Moore A; Den RB; Popovtzer A; Goldvaser H; Gordon N; Goldstein DA
    Head Neck; 2020 Aug; 42(8):1713-1720. PubMed ID: 31976607
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Comparison of two irradiation methods for laryngeal carcinoma in the second degree of clinical progression].
    Mazurkiewicz M; Kozuch-Gdak W; Peszyński J
    Otolaryngol Pol; 1995; 49 Suppl 20():282-5. PubMed ID: 9454160
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Evaluation of short term radiotherapy with small number of fractions (author's transl)].
    Irie G
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Apr; 38(4):354-70. PubMed ID: 673666
    [No Abstract]   [Full Text] [Related]  

  • 85. [Evaluation of the effectiveness of radiotherapy of supraglottic laryngeal cancer in cases of clinically unchanged cervical lymph nodes].
    Skołyszewski J
    Nowotwory; 1979; 29(4):275-80. PubMed ID: 537929
    [No Abstract]   [Full Text] [Related]  

  • 86. [Comparison of the effectiveness of different methods of irradiation using metronidazole as a radiation-sensitizing agent in patients with laryngeal cancer. Controlled clinical studies].
    Gałecki J; Dukowicz A; Hliniak A; Mierzwińska J; Mykowiecka A; Osiadacz W; Prejbisz J; Hipsz K
    Nowotwory; 1989; 39(2):111-5. PubMed ID: 2516308
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Radiotherapy of glottic carcinoma.
    Caldwell WL
    Int J Radiat Oncol Biol Phys; 1977; 2(9-10):1047-8. PubMed ID: 591402
    [No Abstract]   [Full Text] [Related]  

  • 88. The role of tumor size and patient's age as prognostic factors in laryngeal cancer.
    Markou K; Goudakos J; Triaridis S; Konstantinidis J; Vital V; Nikolaou A
    Hippokratia; 2011 Jan; 15(1):75-80. PubMed ID: 21607041
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Moderate-dose radiotherapy for glottic cancer.
    JAMA; 1979 Nov; 242(22):2382. PubMed ID: 490841
    [No Abstract]   [Full Text] [Related]  

  • 90. [Evaluation of radiotherapy failure in laryngeal cancer patients in several Polish medical centers during the years 1980-1982].
    Peszyński J; Skołyszewski J; Gliński B; Kukolewska-Machnicka J; Kozuch-Gdak W; Semczuk L
    Otolaryngol Pol; 1989; 43(2):138-42. PubMed ID: 2608286
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada.
    Hendry JH; Roberts SA; Slevin NJ; Keane TJ; Barton MB; Agren-Cronqvist A
    Radiother Oncol; 1994 Apr; 31(1):14-22. PubMed ID: 8041895
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rethinking the necessity of treating all fields at each radiotherapy session.
    Gitterman M; Littman P; Doppke K; Wang CC
    Radiology; 1975 Nov; 117(2):419-24. PubMed ID: 1178877
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Second primary respiratory tract malignant neoplasms in supraglottic carcinoma.
    Wagenfeld DJ; Harwood AR; Bryce DP; van Nostrand AW; de Boer G
    Arch Otolaryngol; 1981 Mar; 107(3):135-7. PubMed ID: 7469898
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Radiation biology.
    Hall EJ
    Cancer; 1985 May; 55(9 Suppl):2051-7. PubMed ID: 3919919
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The epidemiology of laryngeal cancer in a country on the esophageal cancer belt.
    Saedi B; Razmpa E; Sadeghi M; Mojtahed M; Mojtahed A
    Indian J Otolaryngol Head Neck Surg; 2009 Sep; 61(3):213-7. PubMed ID: 23120638
    [TBL] [Abstract][Full Text] [Related]  

  • 96. New models of dose fractionation in radiotherapy of cancer of the larynx.
    Cova P; Colombo A
    Can J Otolaryngol; 1975; 4(5):934-6. PubMed ID: 1203799
    [No Abstract]   [Full Text] [Related]  

  • 97. Clinical Application Study of Semi-cylindrical Beam Spoiler for Radiation Treatment of Early-stage Glottic Cancer Patients.
    Choi DH; Ahn SH; Ahn WS; Shin SS; Kim JS
    In Vivo; 2022; 36(2):1013-1017. PubMed ID: 35241564
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Moderate hypofractionation for early laryngeal cancer improves local control: a systematic review and meta-analysis.
    Benson R; Prashanth G; Mallick S
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3149-3154. PubMed ID: 32377855
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Supraglottic laryngeal carcinoma.
    Harwood AR; Hill RP
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1759-60. PubMed ID: 6643167
    [No Abstract]   [Full Text] [Related]  

  • 100. Fractionation in radiation therapy: theoretical basis, experimental, and clinical studies.
    Shank B; Chu FF
    Cancer Invest; 1984; 2(2):165-76. PubMed ID: 6733561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.